Journal
SCIENCE
Volume 323, Issue 5916, Pages 934-937Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1166127
Keywords
-
Categories
Funding
- Molecular and Cellular Pharmacology (MCP) Graduate Program
- NIH [T32 GM08688, R01 MH065503, NS30016]
- NIH Ruth L. Kirschstein National Research Service Award [F31 DA022932]
- National Institute on Drug Abuse
Ask authors/readers for more resources
The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast number of synthetic compounds but does not bind opioid peptides; it is currently considered an orphan receptor. The sigma- 1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compound N, N- dimethyltryptamine ( DMT). DMT acts as a hallucinogen, but its receptor target has been unclear. DMT bound to sigma- 1 receptors and inhibited voltage- gated sodium ion ( Na+) channels in both native cardiac myocytes and heterologous cells that express sigma- 1 receptors. DMT induced hypermobility in wild- type mice but not in sigma- 1 receptor knockout mice. These biochemical, physiological, and behavioral experiments indicate that DMT is an endogenous agonist for the sigma- 1 receptor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available